- Report
- November 2022
- 107 Pages
Global
From €3488EUR$3,950USD£3,051GBP
- Report
- October 2023
- 450 Pages
Global
From €1104EUR$1,250USD£966GBP
€2208EUR$2,500USD£1,931GBP
- Report
- October 2023
- 100 Pages
Africa
From €1766EUR$2,000USD£1,545GBP
- Report
- October 2023
- 80 Pages
United States
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1325EUR$1,500USD£1,159GBP
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
India
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
Germany
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
France
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 80 Pages
China
From €1325EUR$1,500USD£1,159GBP
- Report
- October 2023
- 350 Pages
Global
From €1104EUR$1,250USD£966GBP
€2208EUR$2,500USD£1,931GBP
- Report
- June 2023
- 182 Pages
Global
From €3179EUR$3,600USD£2,781GBP
- Report
- June 2023
- 76 Pages
North America
From €1325EUR$1,500USD£1,159GBP
- Report
- June 2025
- 128 Pages
Canada
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 126 Pages
Australia
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 123 Pages
India
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 134 Pages
South Korea
From €5294EUR$5,995USD£4,631GBP
- Report
- June 2025
- 123 Pages
Italy
From €5294EUR$5,995USD£4,631GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more